Inventor · disambiguated record
Colleen Siedem
Also filed as: SIEDEM COLLEEN
10 granted patents·174 citations·filing 1998–2005
91Inventor score
Top patents by PatentIndex Score
10 records- 0196US6037356AHeteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1998·Granted Mar 14, 2000·67 cites·37 claims
- 0288US6706021B2Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2003·Granted Mar 16, 2004·18 cites·42 claims
- 0388US6566379B1Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2002·Granted May 20, 2003·13 cites·42 claims
- 0488US6245763B1Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2000·Granted Jun 12, 2001·13 cites·35 claims
- 0586US7402586B2Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsORTHO MCNEIL PHARM INC·Filed 2005·Granted Jul 22, 2008·4 cites·64 claims
- 0686US6350764B2Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Feb 26, 2002·15 cites·37 claims
- 0784US6472399B2Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Oct 29, 2002·13 cites·26 claims
- 0881US7029654B2Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitorsORTHO MCNEIL PHARM INC·Filed 2003·Granted Apr 18, 2006·9 cites·53 claims
- 0980US6344466B2Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 2001·Granted Feb 5, 2002·13 cites·42 claims
- 1052US6344486B1Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitorsDIMENSIONAL PHARM INC·Filed 1999·Granted Feb 5, 2002·9 cites·64 claims
Join the waitlist — get patent alerts
Get an alert when Colleen Siedem files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →